A novel antibacterial approach of Cecropin-B peptide loaded on chitosan nanoparticles against MDR Klebsiella pneumoniae isolates

Bibliographic Information
Authors: Okasha H.; Dahroug H.; Gouda A.E.; Shemis M.A.
Journal: Amino Acids
Publisher: Springer
Publication Date: 15 November 2023
Volume / Issue: Volume 55 / Issue 12
Pages: 1965–1980
ISSN: 9394451
DOI: 10.1007/s00726-023-03356-4
Scopus: View on Scopus
PubMed: 37966500
Document Type: Article
Access: All Open Access; Green Open Access; Hybrid Gold Open Access
Authors and Affiliations
Okasha H., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Dahroug H., Microbiology Department, Theodor Bilharz Research Institute, Giza, Egypt; Gouda A.E., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Shemis M.A., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Egypt has witnessed the emergence of multidrug-resistant (MDR) Klebsiella pneumoniae, which has posed a serious healthcare challenge. The proper treatment choice for MDR-KP infections is not well determined which renders the problem more complicated, thus making the control of such infections a serious challenge for healthcare professionals. This study aims to encapsulate the cationic antimicrobial peptide; Cecropin-B (Cec-B), to increase its lifetime, drug targeting, and efficacy and study the antimicrobial effect of free and encapsulated recombinant rCec-B peptide on multidrug-resistant K. pneumoniae (MDR-KP) isolates. Fifty isolates were collected from different clinical departments at Theodore Bilharz Research Institute. Minimal inhibitory concentrations (MICs) of rCec-B against MDR-KP isolates were determined by the broth microdilution test. In addition, encapsulation of rCec-B peptide into chitosan nanoparticles and studying its bactericidal effect against MDR-KP isolates were also performed. The relative expression of efflux pump and porin coding genes (ArcrB, TolC, mtdK, and Ompk35) was detected by quantitative PCR in treated MDR-KP bacterial isolates compared to untreated isolates. Out of 60 clinical MDR isolates, 50 were MDR-KP. 60% of the isolates were XDR while 40% were MDR. rCec-B were bactericidal on 21 isolates, then these isolates were subjected to treatment using free nanocapsule in addition to the encapsulated peptide. Free capsules showed a mild cytotoxic effect on MDR-KP at the highest concentration. MIC of encapsulated rCec-B was higher than the free peptide. The expression level of genes encoding efflux and porin (ArcrB, TolC, mtdK, and Ompk35) was downregulated after treatment with encapsulated rCec-B. These findings indicate that encapsulated rCec-B is a promising candidate with potent antibacterial activities against drug-resistant K. pneumoniae. © 2023, The Author(s).
Keywords
Antibacterial; Bactericidal; Cationic antimicrobial peptide; Cecropin; Chitosan; Egypt; Klebsiella pneumoniae; Multidrug-resistant; Nanocapsule; PCR; Anti-Bacterial Agents; Cecropins; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Nanoparticles; Porins; nanoparticle; antiinfective agent; porin; antibacterial activity; ArcrB gene; Article; bacterial gene; bacterium isolation; broth dilution; down regulation; drug cytotoxicity; drug efficacy; drug formulation; drug targeting; drug transport; Fourier transform infrared spectroscopy; gene expression level; gene expression regulation; hemolysis; minimum inhibitory concentration; mtdK gene; multidrug resistant Klebsiella pneumoniae; nanoencapsulation; nonhuman; Ompk35 gene; physical parameters; real time polymerase chain reaction; swelling kinetics; TolC gene; zeta potential; genetics; human; Klebsiella infection; microbial sensitivity test; microbiology
Citation Information
Scopus Citations: 16
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
